Technical Analysis for NITE - Nightstar Therapeutics plc

Grade Last Price % Change Price Change
grade B 25.41 -0.04% -0.01
NITE closed down 0.04 percent on Thursday, June 6, 2019, on 6.26 times normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Flat Flat
See historical NITE trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 67.61%
Calm After Storm Range Contraction 67.61%
20 DMA Support Bullish 71.46%
Slingshot Bullish Bullish Swing Setup 71.46%
Calm After Storm Range Contraction 71.46%
Bearish Engulfing Bearish 67.06%
Fell Below 200 DMA Bearish 67.06%
Slingshot Bullish Bullish Swing Setup 67.06%
Upper Bollinger Band Walk Strength 67.06%
Outside Day Range Expansion 67.06%

Older signals for NITE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Nightstar Therapeutics Limited is a clinical-stage gene therapy company. The Company is focused on developing and commercializing novel one-time treatments for patients suffering from rare inherited retinal diseases that would otherwise progress to blindness. The Company is developing a pipeline of proprietary product candidates that are designed to substantially modify or halt the progression of inherited retinal diseases. The Company’s lead product candidate, NSR-REP1, for the treatment of choroideremia, or CHM, is entering Phase III clinical development. The Company is also conducting a Phase I/II clinical trial with its second product candidate, NSR-RPGR, for the treatment of X-linked retinitis pigmentosa, or XLRP. The Company’s third product candidate, NSR-BEST1, is in preclinical development for the treatment of Best vitelliform macular dystrophy, or Best disease.
Organ Systems Gene Therapy Ophthalmology Vision Blindness Retinitis Pigmentosa Retina Retinal Diseases X Linked Retinitis Pigmentosa Bestrophin 1 Choroideremia
Is NITE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.545
52 Week Low 9.59
Average Volume 175,967
200-Day Moving Average 18.8184
50-Day Moving Average 25.455
20-Day Moving Average 25.461
10-Day Moving Average 25.467
Average True Range 0.0713
ADX 36.19
+DI 20.1162
-DI 17.3826
Chandelier Exit (Long, 3 ATRs ) 25.3461
Chandelier Exit (Short, 3 ATRs ) 25.6039
Upper Bollinger Band 25.5172
Lower Bollinger Band 25.4048
Percent B (%b) 0.05
BandWidth 0.441459
MACD Line 0.058
MACD Signal Line 0.0939
MACD Histogram -0.0359
Fundamentals Value
Market Cap 714.05 Million
Num Shares 28.1 Million
EPS -0.65
Price-to-Earnings (P/E) Ratio -39.09
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.47
Resistance 3 (R3) 25.47 25.46 25.46
Resistance 2 (R2) 25.46 25.44 25.46 25.46
Resistance 1 (R1) 25.43 25.43 25.43 25.43 25.45
Pivot Point 25.42 25.42 25.41 25.42 25.42
Support 1 (S1) 25.39 25.40 25.39 25.39 25.37
Support 2 (S2) 25.38 25.39 25.38 25.36
Support 3 (S3) 25.35 25.38 25.36
Support 4 (S4) 25.35